Great Britain

FDA approves first COVID-19 drug: the antiviral remdesivir

The U.S. Food and Drug Administration has approved the first drug to treat COVID-19: remdesivir an antiviral medicine given through an IV for patients needing hospitalization.

The drug, which California-based Gilead Sciences Inc. is calling Veklury, cut the time to recovery by five days — from 15 days to 10 on average — in a large study led by the U.S. National Institutes of Health.

It had been authorized for use on an emergency basis since spring, and now has become the first drug to win full U.S. approval for treating COVID-19

Gilead says Veklury is approved for people at least 12 years old and weighing at least 88 pounds (40 kilograms) who need hospitalization for their coronavirus infection. It works by inhibiting a substance the virus uses to make copies of itself.

The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content.

Football news:

Ferguson on Rashford's charity: Fiction for a young man. He should give me some advice
A Preston player who twice touched an opponent's genitals was disqualified for 3 matches for aggressive behavior
Atalanta Director: everything is fine with Miranchuk, there are no symptoms of coronavirus
Kovid mocks the Latvian championship: the team got only 8 people (but still did not finish the match)
Gerard Pique: We all hope that Messi will stay at Barca
Agent of coronavirus from the Beginning: I feel fine. A test is a test
Barcelona has reached an agreement in principle with the players to reduce salaries. The club will save 122 million euros